Michael Cruse - Chief Operating Officer at Reneo Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
RPHM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Cruse since 9/17/2023

Holdings reported by Michael Cruse for Reneo Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35.8K $224K $6.28 Dec 9, 2022 Direct
Common Stock 13.7K $86K $6.28 Dec 9, 2022 by Trust
Stock option (right to buy) 125K Dec 9, 2022 Direct Common Stock

Transactions reported by Michael Cruse for Reneo Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.